Skip to main content
. 2017 May 7;19(9):833–839. doi: 10.1111/jch.13007

Table 3.

EQ‐5D‐3L–Reported Degree of Severity at Baseline and at 6 and 12 Months in All Patients

Baseline (n=934) 6 mo (n=934) P Value 12 mo (n=934) P Value
Mobility .625 .274
No problems 72.8 (680) 74.3 (694) 70.8 (661)
Some problems 27.2 (254) 25.6 (239) 29.0 (271)
Severe problems 0.0 (0) 0.1 (1) 0.2 (2)
Self‐care .446 .937
No problems 92.9 (868) 92.8 (867) 92.9 (868)
Some problems 6.2 (58) 6.4 (60) 6.4 (60)
Severe problems 0.9 (8) 0.7 (7) 0.6 (6)
Usual activity .087 .413
No problems 70.9 (662) 73.4 (686) 72.1 (673)
Some problems 26.2 (245) 24.3 (227) 25.9 (242)
Severe problems 2.9 (27) 2.2 (21) 2.0 (19)
Pain/discomfort .289 .190
No problems 52.0 (486) 54.9 (513) 54.2 (506)
Some problems 42.3 (395) 39.8 (372) 41.8 (390)
Severe problems 5.7 (53) 5.2 (49) 4.1 (38)
Anxiety/depression <.001 <.001
No problems 67.6 (631) 74.7 (698) 74.0 (691)
Some problems 29.0 (271) 23.3 (218) 23.8 (222)
Severe problems 3.4 (32) 1.9 (18) 2.2 (21)

Abbreviation: EQ‐5D‐3L, EuroQoL five‐dimensions three‐level questionnaire.

Values are presented as percentage (number).